Article Figures & Tables
Figures
Figure 1: Cost-effectiveness acceptability curves for different prices per blood glucose test strip. These curves show the probability that performing self-monitoring of blood glucose (SMBG) is cost-effective relative to not performing self-monitoring in patients with type 2 diabetes who are not using insulin, across a range of decision-makers’ willingness to pay-thresholds.
Figure 2: Cost-effectiveness acceptability curves for 2-way sensitivity analyses, in which HbA1C estimates of effect and self-monitoring of blood glucose (SMBG) testing frequencies were both varied.